What is the latest market price range of selumetinib?

Selumetinib is an oral small molecule anti-cancer drug that is a MEK inhibitor. It is mainly used to treat certain types of cancer, including neurofibromatosis type 1 (NF1). Selumetinib has good anti-tumor effects by inhibiting the MAPK signaling pathway in tumor cells, thereby preventing the growth and spread of cancer cells.

In China, the original drug of selumetinib has been approved for marketing and has been included in medical insurance, which greatly facilitates patients' access to treatment. Common specifications include 10mg 60 capsules and 25mg 60 capsules. The 10mg specification is priced at more than 20,000 yuan, while the price of 25mg is relatively higher. Compared with the domestic market, selumetinib is more expensive in Europe. The price of a box of 10mg*60 pills may reach more than 50,000 yuan. This is partly due to differences in drug pricing policies and market demand in different countries. In addition, exchange rate fluctuations in the international market will also have an impact on its price.

In order to reduce the financial burden on patients, a variety of generic drugs of selumetinib have appeared on the market. These generic drugs usually have the same active ingredients as the original drugs, and their efficacy and safety have been verified by clinical studies. For example, the generic version of selumetinib produced by Lucius Pharmaceuticals in Laos is priced at 1,000 to more than 2,000 yuan for the same 10mg*60 tablets. Its price advantage allows more patients to receive this treatment.

It is worth noting that although generic drugs have obvious advantages in price, patients still need to be cautious when choosing to ensure the source, quality and effectiveness of the selected drugs. In addition, because the market price will be affected by a variety of factors, such as production costs, distribution channels, national policies, etc., the specific market price range may fluctuate.

Reference materials:https://www.koselugo.com